SlideShare ist ein Scribd-Unternehmen logo
1 von 22
COPD with
Respiratory Failure
Patient Background

 Daishi Hayato
   Age 65
   Male
   Asian American
   Retired
   Wife and 4 adult children
   Father had lung cancer

 Primary Diagnosis:
  Acute respiratory distress, COPD, peripheral vascular disease
    with intermittent claudication
Etiology

 Acute Respiratory Distress (ARDS)
   Occurs when fluid builds up in the alveoli in the lungs
   More fluid in the lungs means less oxygen can reach your
    bloodstream, depriving organs of the oxygen they need to
    function
   Primary symptom: Severe shortness of breath
Etiology

 COPD – Chronic Obstructive Pulmonary Disease
   A progressive disease in which airflow is limited or restricted
   Most times associated with emphysema (destruction of
    alveoli/lungs over time), bronchitis (inflammation of the
    lining of the bronchial tubes), or in rare cases, a genetic
    protein deficiency
   Primary risk factor: Smoking
      Mr. Hayato was diagnosed with emphysema more than
        10 years ago and has a long-standing history of COPD
        secondary to chronic tobacco use of 2 packs per
        day for 50 years
Etiology
Etiology

 Peripheral vascular disease with intermittent claudication
   Peripheral vascular disease occurs when the arteries in the
     extremities become clogged with a fatty substance called
     plaque
   This plaque build up causes atherosclerosis in the arteries,
     obstructing blood flow
   The blocked arteries cause
  claudication or “crampy
     leg” when exercising, with pain
     that comes and goes
Nutrition History

 Appetite: Fair but         BMI: 21.7 kg/m2
  decreasing
                             %UBW: 90%
 Largest meal: Breakfast
                             IBW: 126 lbs
 Highest Weight: 135 lbs
                             %IBW: 97%
 Current Weight: 122 lbs
                             Unintended Weight Loss
 Height: 5’4”
                             Estimated REE needs:
 No previous nutrition       1500 – 1600 kcals
  therapy                      80 - 83 grams protein
At the Hospital

 Chest tube inserted into left thorax with drainage under
  suction

 Endotracheal intubation

 Placed on ventilation
   15 breaths/min with an FiO2 of 100%
   Positive end-expiratory pressure of 6
   Tidal volume of 700 mL

 Daily chest radiographs (X-ray) and ABGs each A.M.
Treatment Plan

 ABG, pulse oximetry, CBC, chemistry panel, UA
  (urinalysis)

 Chest X-ray, ECG, Proventil

 IVF D5 ½ NS at TKO

 Spirogram post nebulizer tx

 NPO

 Increased calorie needs (10-15%)
Tube Feedings

 Initiated on Day 2 of admission
   Isosource @ 25 cc/hr continuously over 24 hours
      Receiving 720 calories and 25.8 grams of protein per day

 High gastric residuals led to discontinued use of enteral
  feeding and initiation of peripheral parenteral nutrition
  (PPN)

 PPN @ 100 cc/hr
   ProcalAmine – 3% glycerin, 3% amino acids
      Receiving 312 calories and 69.6 grams of protein per day
   Regular IV at D5 ½ NS at TKO was discontinued
Tube Feedings

 Day 4: Enteral feeds restarted @ 25 cc/hr, increased to 50
  cc/hr after 12 hours
   ProcalAmine also continued @ 100 cc/hr
   Total Energy Intake: 1,712 calories – excessive

 Respiratory status became worse on Day 5; ProcalAmine
  was discontinued

 Enteral feedings continued until Day 8

 Patient weaned from ventilator Day 8

 Discharged on Day 11
Lab Values:
     Arterial Blood Gases (ABGs)

70
        65                  66
60                60
        56                  57
50                50
                                   pH
40                                 pCO2
        35                  36
30                29               CO2
                                   pO2
20
                                   HCO3
10
        7.2       7.36      7.22
0
     Day 1     Day 3     Day 5
Medical Nutrition Therapy:
       Nutrition Diagnosis


Excessive intake from enteral/parenteral
nutrition related to excessive energy intake
as evidenced by elevated CO2 levels and an
increased RQ
Medical Nutrition Therapy:
              Intervention

 Initiate EN or PN (ND-2.1)

 Modify rate, concentration, composition, or schedule
  (ND-2.2)

 Discontinue EN or PN (ND-2.3)

 Priority modification (E-1.2)

 Goal setting (C-2.2)

 Social support (C-2.5)
Medical Nutrition Therapy:
           Monitor & Evaluation

 Monitor enteral feeding tolerance (residuals) &
  peripheral parenteral nutrition
 Monitor lab values
   Arterial blood gases (ABGs)
   pH
   Blood counts
   RQ

 Monitor weight gain/loss
Medical Nutrition Therapy:
D/C Treatment for Mr. Hayato

 Prevent further weight loss by eating sufficient calories

 Consume a diet rich in antioxidants  fruits, vegetables, and
   fish helps lower incidence of COPD
    Decrease consumption of red meats, refined grains, desserts and
      french fries

 Increased consumption of vitamins C, A, and E and beta-
   carotene to help cope with oxidative damage undergone during
   exacerbation which depletes concentrations of these vitamins

 Monitor phosphate levels for adequacy; crucial for pulmonary
   function because it is essential for synthesis of ATP
Medical Nutrition Therapy:
D/C Treatment for Mr. Hayato

 Assess calcium and vitamin D intake and ensure adequacy to
   help prevent osteoporosis

 Advise patient to consume good sources of protein and
   calories, as well as sources that are nutrient dense

 Rest before meals to avoid fatigue

 Eat smaller, more frequent meals to alleviate feelings of fullness
   and bloating

 Advise exercise, as capable
   Strength/resistance training may help improve skeletal muscle
      function; skeletal muscle dysfunction is often an indicator of
      COPD in its advanced stages
Prognosis


 There is no cure for COPD

 Ways to Improve Overall Quality of Life:
   Smoking Cessation
   Dietary changes
   Taking medications as directed
   Routine medical care and as needed
Question #1




Why are high gastric residuals in tube-fed
           patients dangerous?
Question #2



What primary macronutrient makes it more
      difficult to wean a patient from a
                   ventilator?


                 Why?
Question #3



What two factors indicated that Mr. Hayato
  was receiving excess nutrition from his
       parenteral and enteral feeds?
References

http://www.mayoclinic.com/health/ards/DS00944

http://www.emphysemafoundation.org/pulmonary-disease/57-copd.html

http://www.rxlist.com/procalamine-side-effects-drug-center.htm

http://www.todaysdietitian.com/newarchives/060210p8.shtml

http://www.in.gov/fssa/files/aspiration_prevention_8.pdf.

Medeiros, D., Wildman, R. (2009). “Advanced human nutrition.” Sudbury, MA: Joans and Bartlett Learning, LLC.

Nelms, M., Sucher, K. (2011). “Nutrition therapy and pathophysiology.” Belmont, CA: Wadsworth Cengage Learning.

http://www.umm.edu/patiented/articlesintermittent_claudication_other_symptoms_of_peripheral_artery_disease_000102

http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=66097

http://www.drugs.com/pro/procalamine.html

Weitere ähnliche Inhalte

Was ist angesagt?

Chronic Obstructive Pulmonary Disease Exacerbation
Chronic Obstructive Pulmonary Disease ExacerbationChronic Obstructive Pulmonary Disease Exacerbation
Chronic Obstructive Pulmonary Disease Exacerbation
candicelainereyes
 
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHECOPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
Devawrat Buche
 

Was ist angesagt? (20)

Case presentation on CAD
Case presentation on CADCase presentation on CAD
Case presentation on CAD
 
Asthma Case Presentation
Asthma Case PresentationAsthma Case Presentation
Asthma Case Presentation
 
Chronic Obstructive Pulmonary Disease Exacerbation
Chronic Obstructive Pulmonary Disease ExacerbationChronic Obstructive Pulmonary Disease Exacerbation
Chronic Obstructive Pulmonary Disease Exacerbation
 
COPD case presentation by Amnah AlLail
COPD case presentation by Amnah AlLail COPD case presentation by Amnah AlLail
COPD case presentation by Amnah AlLail
 
A Case Presentation on Pneumonia
A Case Presentation on PneumoniaA Case Presentation on Pneumonia
A Case Presentation on Pneumonia
 
Arterial and Venous Blood Gas Analysis Edward Omron MD, MPH
Arterial and Venous Blood Gas Analysis   Edward Omron MD, MPHArterial and Venous Blood Gas Analysis   Edward Omron MD, MPH
Arterial and Venous Blood Gas Analysis Edward Omron MD, MPH
 
COPD with RV failure - Case Presentation
COPD with RV failure - Case PresentationCOPD with RV failure - Case Presentation
COPD with RV failure - Case Presentation
 
ARDS (Case study)
ARDS (Case study)ARDS (Case study)
ARDS (Case study)
 
a case study on COPD with hypertension
a case study on COPD with hypertension a case study on COPD with hypertension
a case study on COPD with hypertension
 
Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!Case study on Heart Failure by RxVichuZ!
Case study on Heart Failure by RxVichuZ!
 
case study on Tuberculosis
case study on Tuberculosis case study on Tuberculosis
case study on Tuberculosis
 
Clinical correlation hyperlipidemia
Clinical correlation  hyperlipidemiaClinical correlation  hyperlipidemia
Clinical correlation hyperlipidemia
 
CASE PRESENTATION ON ARF
CASE PRESENTATION ON ARFCASE PRESENTATION ON ARF
CASE PRESENTATION ON ARF
 
COPD exacerbation case presentation and disease overview
COPD exacerbation case presentation and disease overview COPD exacerbation case presentation and disease overview
COPD exacerbation case presentation and disease overview
 
Case presentation of copd
Case presentation of copdCase presentation of copd
Case presentation of copd
 
Case presentation on coronary artery disease
Case presentation on coronary artery diseaseCase presentation on coronary artery disease
Case presentation on coronary artery disease
 
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHECOPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
COPD AND ICU MANAGEMENT : DR DEVAWRAT BUCHE
 
Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation Diabetic Ketoacidosis Case presentation
Diabetic Ketoacidosis Case presentation
 
11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease11. a case study on chronic alcoholic liver disease
11. a case study on chronic alcoholic liver disease
 
Asthma case study by abhishek pandey
Asthma case study by abhishek pandeyAsthma case study by abhishek pandey
Asthma case study by abhishek pandey
 

Ähnlich wie COPD with Respiratory Failure

Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02
Dana Perez
 
COPDTeam Members Adewale OkanlawonFatimoh OlatejuUchenn
COPDTeam Members Adewale OkanlawonFatimoh OlatejuUchennCOPDTeam Members Adewale OkanlawonFatimoh OlatejuUchenn
COPDTeam Members Adewale OkanlawonFatimoh OlatejuUchenn
AlleneMcclendon878
 
Major case chc
Major case chcMajor case chc
Major case chc
abortnick
 
Major case chc
Major case chcMajor case chc
Major case chc
abortnick
 
Upper GI case study
Upper GI case studyUpper GI case study
Upper GI case study
Yeyan Jin
 
Cystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study PresentationCystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study Presentation
Mary Rodavich
 
Major Case Study Presentation
Major Case Study PresentationMajor Case Study Presentation
Major Case Study Presentation
bjazexhiu
 
505301908-dietetic-internship-mini-case-study-powerpoint.pptx
505301908-dietetic-internship-mini-case-study-powerpoint.pptx505301908-dietetic-internship-mini-case-study-powerpoint.pptx
505301908-dietetic-internship-mini-case-study-powerpoint.pptx
KhushwantPatidar2
 
Nutrition and Immunonutrition in ICU
Nutrition and Immunonutrition in ICUNutrition and Immunonutrition in ICU
Nutrition and Immunonutrition in ICU
nutritionistrepublic
 

Ähnlich wie COPD with Respiratory Failure (20)

Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02
 
NUTRITION IN CRITICALLY ILL PATIENTS.pdf
NUTRITION IN CRITICALLY ILL PATIENTS.pdfNUTRITION IN CRITICALLY ILL PATIENTS.pdf
NUTRITION IN CRITICALLY ILL PATIENTS.pdf
 
Case Study
Case StudyCase Study
Case Study
 
COPDTeam Members Adewale OkanlawonFatimoh OlatejuUchenn
COPDTeam Members Adewale OkanlawonFatimoh OlatejuUchennCOPDTeam Members Adewale OkanlawonFatimoh OlatejuUchenn
COPDTeam Members Adewale OkanlawonFatimoh OlatejuUchenn
 
Nutrition COPD.ppt
Nutrition COPD.pptNutrition COPD.ppt
Nutrition COPD.ppt
 
Major case chc
Major case chcMajor case chc
Major case chc
 
Major case chc
Major case chcMajor case chc
Major case chc
 
Surgical Nutrition
Surgical NutritionSurgical Nutrition
Surgical Nutrition
 
Updated tpn last
Updated tpn lastUpdated tpn last
Updated tpn last
 
Upper GI case study
Upper GI case studyUpper GI case study
Upper GI case study
 
Cystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study PresentationCystic Fibrosis Nutritional Case Study Presentation
Cystic Fibrosis Nutritional Case Study Presentation
 
Case pancretitis
Case pancretitisCase pancretitis
Case pancretitis
 
Major Case Study Presentation
Major Case Study PresentationMajor Case Study Presentation
Major Case Study Presentation
 
Fwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessmentFwd: Bambury tutorial on preop assessment
Fwd: Bambury tutorial on preop assessment
 
Nutrition
NutritionNutrition
Nutrition
 
Nutrition Therapy in Pulmonary Diseases.pptx
Nutrition Therapy in Pulmonary Diseases.pptxNutrition Therapy in Pulmonary Diseases.pptx
Nutrition Therapy in Pulmonary Diseases.pptx
 
Achalasia with Aspiration Pneumonia
Achalasia with Aspiration PneumoniaAchalasia with Aspiration Pneumonia
Achalasia with Aspiration Pneumonia
 
505301908-dietetic-internship-mini-case-study-powerpoint.pptx
505301908-dietetic-internship-mini-case-study-powerpoint.pptx505301908-dietetic-internship-mini-case-study-powerpoint.pptx
505301908-dietetic-internship-mini-case-study-powerpoint.pptx
 
Nutrition in COPD.pptx
Nutrition in COPD.pptxNutrition in COPD.pptx
Nutrition in COPD.pptx
 
Nutrition and Immunonutrition in ICU
Nutrition and Immunonutrition in ICUNutrition and Immunonutrition in ICU
Nutrition and Immunonutrition in ICU
 

COPD with Respiratory Failure

  • 2. Patient Background  Daishi Hayato  Age 65  Male  Asian American  Retired  Wife and 4 adult children  Father had lung cancer  Primary Diagnosis: Acute respiratory distress, COPD, peripheral vascular disease with intermittent claudication
  • 3. Etiology  Acute Respiratory Distress (ARDS)  Occurs when fluid builds up in the alveoli in the lungs  More fluid in the lungs means less oxygen can reach your bloodstream, depriving organs of the oxygen they need to function  Primary symptom: Severe shortness of breath
  • 4. Etiology  COPD – Chronic Obstructive Pulmonary Disease  A progressive disease in which airflow is limited or restricted  Most times associated with emphysema (destruction of alveoli/lungs over time), bronchitis (inflammation of the lining of the bronchial tubes), or in rare cases, a genetic protein deficiency  Primary risk factor: Smoking  Mr. Hayato was diagnosed with emphysema more than 10 years ago and has a long-standing history of COPD secondary to chronic tobacco use of 2 packs per day for 50 years
  • 6. Etiology  Peripheral vascular disease with intermittent claudication  Peripheral vascular disease occurs when the arteries in the extremities become clogged with a fatty substance called plaque  This plaque build up causes atherosclerosis in the arteries, obstructing blood flow  The blocked arteries cause claudication or “crampy leg” when exercising, with pain that comes and goes
  • 7. Nutrition History  Appetite: Fair but  BMI: 21.7 kg/m2 decreasing  %UBW: 90%  Largest meal: Breakfast  IBW: 126 lbs  Highest Weight: 135 lbs  %IBW: 97%  Current Weight: 122 lbs  Unintended Weight Loss  Height: 5’4”  Estimated REE needs:  No previous nutrition 1500 – 1600 kcals therapy  80 - 83 grams protein
  • 8. At the Hospital  Chest tube inserted into left thorax with drainage under suction  Endotracheal intubation  Placed on ventilation  15 breaths/min with an FiO2 of 100%  Positive end-expiratory pressure of 6  Tidal volume of 700 mL  Daily chest radiographs (X-ray) and ABGs each A.M.
  • 9. Treatment Plan  ABG, pulse oximetry, CBC, chemistry panel, UA (urinalysis)  Chest X-ray, ECG, Proventil  IVF D5 ½ NS at TKO  Spirogram post nebulizer tx  NPO  Increased calorie needs (10-15%)
  • 10. Tube Feedings  Initiated on Day 2 of admission  Isosource @ 25 cc/hr continuously over 24 hours  Receiving 720 calories and 25.8 grams of protein per day  High gastric residuals led to discontinued use of enteral feeding and initiation of peripheral parenteral nutrition (PPN)  PPN @ 100 cc/hr  ProcalAmine – 3% glycerin, 3% amino acids  Receiving 312 calories and 69.6 grams of protein per day  Regular IV at D5 ½ NS at TKO was discontinued
  • 11. Tube Feedings  Day 4: Enteral feeds restarted @ 25 cc/hr, increased to 50 cc/hr after 12 hours  ProcalAmine also continued @ 100 cc/hr  Total Energy Intake: 1,712 calories – excessive  Respiratory status became worse on Day 5; ProcalAmine was discontinued  Enteral feedings continued until Day 8  Patient weaned from ventilator Day 8  Discharged on Day 11
  • 12. Lab Values: Arterial Blood Gases (ABGs) 70 65 66 60 60 56 57 50 50 pH 40 pCO2 35 36 30 29 CO2 pO2 20 HCO3 10 7.2 7.36 7.22 0 Day 1 Day 3 Day 5
  • 13. Medical Nutrition Therapy: Nutrition Diagnosis Excessive intake from enteral/parenteral nutrition related to excessive energy intake as evidenced by elevated CO2 levels and an increased RQ
  • 14. Medical Nutrition Therapy: Intervention  Initiate EN or PN (ND-2.1)  Modify rate, concentration, composition, or schedule (ND-2.2)  Discontinue EN or PN (ND-2.3)  Priority modification (E-1.2)  Goal setting (C-2.2)  Social support (C-2.5)
  • 15. Medical Nutrition Therapy: Monitor & Evaluation  Monitor enteral feeding tolerance (residuals) & peripheral parenteral nutrition  Monitor lab values  Arterial blood gases (ABGs)  pH  Blood counts  RQ  Monitor weight gain/loss
  • 16. Medical Nutrition Therapy: D/C Treatment for Mr. Hayato  Prevent further weight loss by eating sufficient calories  Consume a diet rich in antioxidants  fruits, vegetables, and fish helps lower incidence of COPD  Decrease consumption of red meats, refined grains, desserts and french fries  Increased consumption of vitamins C, A, and E and beta- carotene to help cope with oxidative damage undergone during exacerbation which depletes concentrations of these vitamins  Monitor phosphate levels for adequacy; crucial for pulmonary function because it is essential for synthesis of ATP
  • 17. Medical Nutrition Therapy: D/C Treatment for Mr. Hayato  Assess calcium and vitamin D intake and ensure adequacy to help prevent osteoporosis  Advise patient to consume good sources of protein and calories, as well as sources that are nutrient dense  Rest before meals to avoid fatigue  Eat smaller, more frequent meals to alleviate feelings of fullness and bloating  Advise exercise, as capable  Strength/resistance training may help improve skeletal muscle function; skeletal muscle dysfunction is often an indicator of COPD in its advanced stages
  • 18. Prognosis  There is no cure for COPD  Ways to Improve Overall Quality of Life:  Smoking Cessation  Dietary changes  Taking medications as directed  Routine medical care and as needed
  • 19. Question #1 Why are high gastric residuals in tube-fed patients dangerous?
  • 20. Question #2 What primary macronutrient makes it more difficult to wean a patient from a ventilator? Why?
  • 21. Question #3 What two factors indicated that Mr. Hayato was receiving excess nutrition from his parenteral and enteral feeds?
  • 22. References http://www.mayoclinic.com/health/ards/DS00944 http://www.emphysemafoundation.org/pulmonary-disease/57-copd.html http://www.rxlist.com/procalamine-side-effects-drug-center.htm http://www.todaysdietitian.com/newarchives/060210p8.shtml http://www.in.gov/fssa/files/aspiration_prevention_8.pdf. Medeiros, D., Wildman, R. (2009). “Advanced human nutrition.” Sudbury, MA: Joans and Bartlett Learning, LLC. Nelms, M., Sucher, K. (2011). “Nutrition therapy and pathophysiology.” Belmont, CA: Wadsworth Cengage Learning. http://www.umm.edu/patiented/articlesintermittent_claudication_other_symptoms_of_peripheral_artery_disease_000102 http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=66097 http://www.drugs.com/pro/procalamine.html